Ultime prove

EudraCT Number: 2006-003302-25

Sponsor Protocol Number: PRG-OXYCODONE-06/01

Start Date: 2006-11-30

Sponsor Name: Barts and The London NHS Trust

Full Title: A prospective, randomised, double-blind, placebo-controlled trial to assess the respiratory effects of oxycodone versus morphine in anaesthetised patients

Medical condition: Patients scheduled to undergo surgery of more than 30 minutes duration under general anaesthesia will be recruited. We are not investigating a medical disease.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2006-001062-17

Sponsor Protocol Number: ASF-1096-201/250912BS

Start Date: 2006-11-30

Sponsor Name: Astion Danmark A/S

Full Title: Efficacy and safety of ASF-1096 cream 0.5% in the treatment of patients with newly developed discoid lupus erythymatosus (DLE) lesions. A multi centre clinical phase 2, placebo controlled and doubl...

Medical condition: Male or female patients with a clinical diagnosis of either Discoid Lupus Erythmatosus or Systemic Lupus Erythmatosus and at least one newly developed, sharply demarcated DLE lesion.

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10025138	Lupus erythematosus discoides	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) SE (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2006-001254-27

Sponsor Protocol Number: P051205

Start Date: 2006-11-30

Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

Full Title: Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus

Medical condition: Patients atteints de mucoviscidose, chez lesquels un diagnostic de diabète a été fait par hyperglycémie provoquée orale (HGPO)

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10012594	DIABETES	PT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-001672-39

Sponsor Protocol Number: CARDIOCC2004

Start Date: 2006-11-30

Sponsor Name: Dr Moya Mur

Full Title: EFECTO PROTECTOR DE LA ATORVASTATINA SOBRE LA FUNCION MICROVASCULAR CORONARIA Y FUNCION COGNITIVA CEREBRAL EN PACIENTES SOMETIDOS A REVASCULARIZACION CORONARIA

Medical condition: CARDIOPATIA ISQUEMICA

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-002165-39

Sponsor Protocol Number: P04887

Start Date: 2006-11-30

Sponsor Name: Schering Plough Research Institute, a division of Schering Corporation

Full Title: Study of the Efficacy and Safety of SCH486757 in Subjects With Chronic Idiopathic Cough

Medical condition: Chronic Idiopathic Cough

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2006-002324-41

Sponsor Protocol Number: PH2/051

Start Date: 2006-11-30

Sponsor Name: Cancer Research UK

Full Title: A Cancer Research UK Randomised Multicentre Phase II Trial of the DNA-hypomethylating Agent, 5-Aza-2'-deoxycytidine(Decitabine) given intravenously in Combination with Carboplatin, versus Carboplat...

Medical condition: Progressive, advanced ovarian cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10033128	Ovarian cancer	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: GB (Prematurely Ended)

Trial results: View results

EudraCT Number: 2006-003142-42

Sponsor Protocol Number: SC12267-3-2005

Start Date: 2006-11-30

Sponsor Name: 4SC AG

Full Title: A Randomized, Double Blind, Placebo-controlled, Proof of Concept Study to evaluate Efficacy, Safety and Pharmacokinetics of two Different Doses of SC12267 (20mg, 35 mg) in Patients with Rheumatoid ...

Medical condition: Active Rheumatoid Arthritis

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10039073	Rheumatoid arthritis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2006-002757-72

Sponsor Protocol Number: NEOSH101-CLIN-AGA003

Start Date: 2006-11-30

Sponsor Name: Neosil Inc.

Full Title: A Phase 2 Multicenter, Randomized, Placebo- and Comparator Controlled, Double-Blind Parallel Group Study to Evaluate the Safety and Efficacy of Topical NEOSH101 in the Treatment of Androgenetic Alo...

Medical condition: The study will be performed in male subjects with androgenetic alopecia, Norwood -Hamilton grades III - IV.

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10001760	Alopecia	LLT

Population Age: Adults

Gender: Male

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2006-004977-91

Sponsor Protocol Number: ANA06104

Start Date: 2006-11-30

Sponsor Name: Universitätsklinikum Mannheim, Klinik für Anästhesiologie

Full Title: Inhalative Sedierung mit Sevofluran im Vergleich zu Propofol bei beatmeten, postoperativen Intensivpatienten – Einfluss auf Extubationszeiten und Aufwachverhalten, Nieren- und Leberfunktion, Hämody...

Medical condition: Der Einsatz von Sevofluran im Vergleich zur konventionellen Sedierung mit Propofol soll in Bezug auf Sedierungsgrad unter Beatmung, Extubationszeit und Aufwachverhalten, Hämodynamik, Kardioprotekti...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2006-005096-17

Sponsor Protocol Number: 0633-009

Start Date: 2006-11-30

Sponsor Name: Merck & Co., Inc

Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study, Conducted Under In-House blinding Conditions of MK-0633 in Patients With COPD

Medical condition: Chronic Obstructive Pulmonary Disease (COPD)

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: LT (Completed)

Trial results: View results

Ultime prove

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici